Genacol
A Unique Patented Technology
Thanks to Genacol’s exclusive patented enzymatic hydrolysis technology, the AminoLock® Sequence Technology, we obtain ultra-hydrolyzed collagen from a bovine source with the lowest molecular weight in the world, at less than 1 kilodalton (kDa).
This exclusive Genacol® technology used to reduce joint pain associated with osteoarthritis is patented!
Three clinical studies demonstrate its effectiveness
To date, three independent clinical studies on the effectiveness of AminoLock® Collagen have been performed. Thanks to serious and supervised protocols, our research teams have shown that AminoLock® Collagen is a natural and effective solution for joint health and can provide relief in people living with osteoarthritis.